These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23072733)

  • 1. Systemic corticosteroid for COPD exacerbations, whether the higher dose is better? A meta-analysis of randomized controlled trials.
    Cheng T; Gong Y; Guo Y; Cheng Q; Zhou M; Shi G; Wan H
    Clin Respir J; 2013 Oct; 7(4):305-18. PubMed ID: 23072733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Different Doses of Systemic Corticosteroids in COPD Exacerbation.
    Pu X; Liu L; Feng B; Wang M; Dong L; Zhang Z; Fan Q; Li Y; Wang G
    Respir Care; 2021 Feb; 66(2):316-326. PubMed ID: 33051255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Woods JA; Wheeler JS; Finch CK; Pinner NA
    Int J Chron Obstruct Pulmon Dis; 2014; 9():421-30. PubMed ID: 24833897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease?
    Vondracek SF; Hemstreet BA
    Pharmacotherapy; 2006 Apr; 26(4):522-32. PubMed ID: 16553512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China.
    Zhang J; Yao W; You X; Liu T; Liu Y
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1195-1207. PubMed ID: 31213797
    [No Abstract]   [Full Text] [Related]  

  • 7. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease.
    Kiser TH; Allen RR; Valuck RJ; Moss M; Vandivier RW
    Am J Respir Crit Care Med; 2014 May; 189(9):1052-64. PubMed ID: 24617842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews.
    Wood-Baker R; Walters J; Walters EH
    Respir Med; 2007 Mar; 101(3):371-7. PubMed ID: 16962307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases].
    Chen G; Xie CM; Luo YF
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Aug; 31(8):577-80. PubMed ID: 19080399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
    Sivapalan P; Rutishauser J; Ulrik CS; Leuppi JD; Pedersen L; Mueller B; Eklöf J; Biering-Sørensen T; Gottlieb V; Armbruster K; Janner J; Moberg M; Lapperre TS; Nielsen TL; Browatzki A; Mathioudakis A; Vestbo J; Schüetz P; Jensen JU
    Respir Res; 2021 May; 22(1):155. PubMed ID: 34020641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meta-analysis of efficacy and safety of oral theophylline in chronic obstructive pulmonary disease].
    Wang CH; Zhang Q; Li M; Fu PF; Yan ZM; Peng AM; Zhang GL
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):540-6. PubMed ID: 20367966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
    Urwyler P; Boesing M; Abig K; Cattaneo M; Dieterle T; Zeller A; Bachler H; Markun S; Senn O; Merlo C; Essig S; Ullmer E; Rutishauser J; Schuurmans MM; Leuppi JD
    Trials; 2019 Dec; 20(1):727. PubMed ID: 31842993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease.
    Lindenauer PK; Pekow PS; Lahti MC; Lee Y; Benjamin EM; Rothberg MB
    JAMA; 2010 Jun; 303(23):2359-67. PubMed ID: 20551406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroids in acute exacerbations of chronic obstructive pulmonary disease: are nebulized and systemic forms comparable?
    Gunen H; Mirici A; Meral M; Akgün M
    Curr Opin Pulm Med; 2009 Mar; 15(2):133-7. PubMed ID: 19532028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
    Daniels JM; Snijders D; de Graaff CS; Vlaspolder F; Jansen HM; Boersma WG
    Am J Respir Crit Care Med; 2010 Jan; 181(2):150-7. PubMed ID: 19875685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis.
    Yao GY; Ma YL; Zhang MQ; Gao ZC
    Respiration; 2013; 86(3):254-60. PubMed ID: 23817204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term versus longer duration of glucocorticoid therapy for exacerbations of chronic obstructive pulmonary disease.
    Ma Z; Zhang W
    Pulm Pharmacol Ther; 2016 Oct; 40():84-90. PubMed ID: 27506415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Clinical Outcomes Between Nebulized and Systemic Corticosteroids in the Treatment of Acute Exacerbation of COPD in China (CONTAIN Study): A Post Hoc Analysis.
    Chen Y; Liu Y; Zhang J; Yao W; Yang J; Li F; Lu L; Zheng J; Han X; Xu JF
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2343-2353. PubMed ID: 33061352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
    Singh S; Amin AV; Loke YK
    Arch Intern Med; 2009 Feb; 169(3):219-29. PubMed ID: 19204211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.